Development of a Novel Therapeutic to Treat White Matter Injury in Premature Infants
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
Tellus Therapeutics, Inc.
Award Date
Award Amount
250,000
Program Name
Small Business Research Loan
Program Category
Business Financing
Principal Investigator
Jason Kralic
Fiscal Year
2020
Region
Research Triangle
Project Description:
Tellus Therapeutics, Inc. is developing a treatment for perinatal white matter injury (WMI) which is a factor leading to neurodevelopmental deficit in premature births. The Company was awarded a $250,000 SRL to support its IND-enabling development program for its lead molecule that has been shown to promote myelination and subsequent reversal of motor deficits in animal models of WMI.